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Background: Multimorbidity is increasingly recognized as a major public health challenge of modern societies.
However, knowledge about the size of the population suffering from multimorbidity and the type of
multimorbidity is scarce. The objective of this study was to present an overview of the prevalence of multimorbidity
and comorbidity of chronic diseases in the Dutch population and to explore disease clustering and common
comorbidities.
Methods: We used 7 years data (2002–2008) of a large Dutch representative network of general practices (212,902
patients). Multimorbidity was defined as having two or more out of 29 chronic diseases. The prevalence of
multimorbidity was calculated for the total population and by sex and age group. For 10 prevalent diseases among
patients of 55 years and older (N = 52,014) logistic regressions analyses were used to study disease clustering and
descriptive analyses to explore common comorbid diseases.
Results: Multimorbidity of chronic diseases was found among 13% of the Dutch population and in 37% of those
older than 55 years. Among patients over 55 years with a specific chronic disease more than two-thirds also had
one or more other chronic diseases. Most disease pairs occurred more frequently than would be expected if
diseases had been independent. Comorbidity was not limited to specific combinations of diseases; about 70% of
those with a disease had one or more extra chronic diseases recorded which were not included in the top five of
most common diseases.
Conclusion: Multimorbidity is common at all ages though increasing with age, with over two-thirds of those with
chronic diseases and aged 55 years and older being recorded with multimorbidity. Comorbidity encompassed
many different combinations of chronic diseases. Given the ageing population, multimorbidity and its
consequences should be taken into account in the organization of care in order to avoid fragmented care, in
medical research and healthcare policy.
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The presence of multiple coexistent chronic diseases is
increasingly recognized as a major public health chal-
lenge of modern societies [1,2]. Challenges include opti-
malization of individuals’ health despite multimorbidity
and the organisation and provision of health care for
multimorbid patients. A first step in meeting these chal-
lenges is to provide insight into the size of the* Correspondence: Sandra.van.oostrom@rivm.nl
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distribution, and reproduction in any mediumpopulation suffering from multimorbidity, and the type
of multimorbidity. Several studies on these figures are
now available, showing high prevalences of multimorbid-
ity [3-7]. Until now however, the distribution and com-
bination of specific diseases received very little attention
[8]. Health care needs of patients with multiple chronic
conditions not only depend on the number but also, and
maybe even more so, on the type of co-occurring dis-
eases. With the ageing population and the accompanying
rise in multimorbidity, the burden of chronically ill on
health service capacity and costs is high [9] and is
expected to rise in the future. Insight into combinationsentral Ltd. This is an Open Access article distributed under the terms of the
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and improving (the organization of) health care services.
In this paper we analyze the prevalence of multimor-
bidity of chronic diseases by age and sex and the cluster-
ing of chronic diseases on the basis of electronic medical
records in a representative sample of Dutch general
practices. For a selection of 10 specific diseases we also
present a detailed picture of the comorbidity, i.e. the
type and prevalence of additional diseases among that
specific disease.
Methods
Study design & participants
We used a longitudinal dataset of electronic medical
records of over 350,000 patients in a representative sam-
ple of 92 general practices that participate in the Nether-
lands Information Network of General Practice (LINH),
covering circa 2% of the total Dutch population [10].
General practices within this network are evenly distrib-
uted across the Netherlands. The listed population and
the general practices are representative for the Dutch
population and the Dutch general practitioners, respect-
ively. In the Netherlands, all individuals are obligatory
listed in a general practice, with exception of a small,
very old part of the Dutch population in nursing homes.
Therefore, the listed population can be used as the de-
nominator in population based epidemiological studies.
The prevalence of multimorbidity was analysed using
LINH data from 2002 to 2008. LINH is registered with
the Dutch Data Protection Authority; data are handled
according to the data protection guidelines of the au-
thority. According to Dutch legislation, studies using this
kind of observational data do not require medical ethical
approval.
Dataset
LINH includes routinely recorded data on consultations,
including drug prescriptions and referrals. Diagnostic
codes were recorded with consultations, drug prescrip-
tions, and referrals, according to the International Clas-
sification of Primary Care (ICPC) [11]. Episodes of care
were constructed and included all patients contacts and
drug prescriptions pertaining to a specific health prob-
lem [12]. Thus two consultations for the same health
problem are grouped into one episode of care. Consider,
for instance, a patient who visits the general practitioner
with a chronic cough, and a few months later the same
patient is diagnosed with COPD. Most likely, both diag-
noses refer to the same health problem and to avoid
double counting the two diagnoses were grouped into
one episode of care named COPD. Another example is a
patient with symptoms of breathlessness and a diagnosis
of heart failure a few weeks later, these health problems
were grouped into one episode of heart failure. Theseepisodes were constructed by EPICON, an algorithm to
group ICPC-coded contact records from electronic med-
ical records in general practice into episodes of care
[13,14].
For prevalence calculations the data from general
practices should meet standards for completeness, i.e.
for each general practice the percentage of valid ICPC
codes should be 60% or more and the registration of
morbidity and prescriptions must have occurred con-
tinuously over each year [10].
Multimorbidity and comobidity
Multimorbidity is defined as the co-occurrence of two
or more chronic diseases within one person in a specific
period of time [15]. Comorbidity refers to the presence
of at least one extra chronic disease along with a chronic
disease of interest [16]. Chronic diseases are defined as
irreversible conditions without complete recovery or
relatively long-lasting conditions. Diseases were selected
based on high prevalence and a chronic and severe char-
acter from a standard list of chronic conditions for pri-
mary care [17]. This resulted in 29 chronic diseases,
presented with ICPC codes in Table 1 [17]. Comorbidity
was explored for 10 chronic diseases which are prevalent
among older patients: diabetes mellitus, coronary heart
disease, osteoarthritis, chronic obstructive pulmonary
disease (COPD), chronic neck- or back disorders, cancer,
stroke, depression, heart failure, and anxiety disorders.
Prevalence
Given that diagnoses are recorded based on patient con-
tacts, the prevalence of some chronic diseases is under-
estimated when medical records from one year are used.
In general, patients with diabetes or COPD visit their
general practitioner frequently throughout a year but
patients with osteoarthritis or asthma for example visit
their general practitioner infrequently, sometimes even
less than once a year. Therefore, only patients registered
for a minimum period of 3 consecutive years in a gen-
eral practice within the LINH network were selected.
Analyses
The selection of patients registered for a minimum
period of 3 consecutive years resulted in a study popula-
tion of 212,902 patients registered with 59 general
practices.
Sex and age standardization was applied in all preva-
lence estimates to account for differences with the
Dutch population in 2008 (http://statline.cbs.nl). The
prevalence of chronic diseases and multimorbidity was
defined as the number of patients with one or more dis-
eases divided by the total number of 212,902 registered
patients. In addition, prevalence estimates were stratified
according to sex and age groups. To determine
Table 1 Selection of 29 chronic diseases with ICPC-1
codes
Chronic disease ICPC-1 code
Tuberculosis A70
HIV/AIDS B90
Cancer A79, B72, B73, D74, D75, D77,
L71, N74, R84, R85, S77, T71,
U75, U76, U77, W72, X75, X76,
X77, Y77, Y78
Gastric or duodenal ulcer D85, D86
Chronic enteritis/colitis
ulcerosa
D94
Visual disorder F83, F84, F92, F93, F94
Hearing disorder H84, H85
Congenital
cardiovascular anomaly
K73
Coronary heart disease K74, K75, K76
Heart failure K77
Stroke (including TIA) K89, K90
Chronic back or
neck disorder
L83, L84, L85, L86
Rheumatoid arthritis L88
Osteoarthritis L89, L90, L91
Osteoporosis L95
Congenital
neurological anomaly
N85
Multiple sclerosis N86
Parkinson’s disease N87
Epilepsy N88
Chronic alcohol abuse P15
Dementia P70
Schizophrenia P72
Anxiety disorder,
neurosis, PTSS
P74, P79
Depressive disorder P76
Mental retardation P85
Chronic obstructive
pulmonary disease
R91, R95
Asthma R96
Anorexia T06
Diabetes mellitus T90
The selection of chronic diseases is based on ‘Defining chronic conditions for
primary care using ICPC-2: supplementary data'.[17] ICPC-2 codes are encoded
into ICPC-1 codes.
Table 2 Prevalence rates of patients with chronic diseases
and patients with multimorbidity according to sex and
age, LINH 2002-2008
N Prevalence rate
of patients
with chronic
diseases (%)*
Prevalence
rate of
multimorbid
patients (%)*
Total 212,902 33.7% 12.9%
Men 105,547 30.7% 10.9%
Women 107,355 36.6% 15.0%
0-14 years 38,944 12.6% 0.6%
15-24 years 26,718 15.2% 2.0%
25-54 years 95,226 30.0% 8.1%
55-64 years 22,592 52.9% 22.7%
65-74 years 17,465 70.0% 39.1%
74+ years 11,957 83.5% 59.2%
* According to the selection of 29 chronic diseases in Table 1.
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ease, once recorded, remains prevalent during all follow-
up years in the registration (recovery is not possible).
Analyses for clustering and comorbidity were
restricted to 52,014 patients of 55 years and older. If dis-
eases are completely independent of one another, they
can be expected to co-occur at a rate which equals theproduct of the prevalence rates of the separate diseases
[5]. For some pairs of diseases, the rate of co-occurrence
may be higher than expected, which is referred to as dis-
ease clustering [18]. Clustering of chronic diseases is
determined by the ratio of the observed prevalence rate
and the expected prevalence rate of the pair of diseases.
Logistic regression analyses adjusted for sex and age
were used to investigate disease clustering.
For each of the 10 chronic diseases the proportion
patients without comorbidity and those with 1, 2, 3, and
4 or more comorbid diseases was calculated. Finally, the
five most prevalent comorbid chronic diseases (from 28
other diseases) were determined for the 10 specific
diseases.
All analyses were performed in SAS version 9.2 (SAS
Institute, Cary, North Carolina, USA).Results
One-third of all registered patients had at least one
chronic disease out of 29 chronic diseases (all ages) and
about 13% had multimorbidity (Table 2). The prevalence
rate of chronic diseases and multimorbidity is higher for
women and higher age groups. Of patients of 75 years
and older 84% had a chronic disease and 59% had more
than one chronic disease. In total, 37% of all patients of
55 years and older was known with multimorbidity.
The prevalence estimates for pairs of chronic diseases
in the population of 55 years and older are presented in
Table 3. The prevalence of co-occuring diabetes and cor-
onary heart disease was 3.6% for example, and COPD
and osteoarthritis co-occur in 1.7% of the patients. Most
odds ratios are significantly higher than 1.0, indicating
that almost all pairs of chronic diseases co-occur more
frequently than expected on basis of statistical
Table 3 Prevalence (P) co-occuring chronic diseases (%)1 and the sex and age adjusted odds ratio (OR) for clustering
for patients of 55 years and older2, LINH 2002–2008
Coronary heart
disease
Osteoarthritis COPD Chronic neck
or back disorder
Cancer Stroke Depression Heart
failure
Anxiety
disorder
P OR P OR P OR P OR P OR P OR P OR P OR P OR
Diabetes mellitus 3.6 1.9*3 2.8 1.1* 2.1 1.3* 2.5 1.3* 1.9 1.1 1.9 1.6* 1.4 1.2* 2.2 1.7* 0.5 1.1
Coronary
heart disease
2.5 1.3* 2.2 1.6* 2.3 1.6* 1.8 1.2* 1.5 1.3* 1.3 1.5* 2.8 3.7* 0.4 1.5*
Osteoarthritis 1.7 1.2* 2.8 2.0* 1.7 1.1* 1.2 1.0* 1.4 1.4* 1.6 1.3* 0.4 1.1
COPD 1.5 1.4* 1.4 1.3* 1.0 1.3* 1.0 1.7* 1.9 3.4* 0.4 1.7*
Chronic neck or
back disorder
1.4 1.2* 1.0 1.3* 1.2 1.5* 0.9 1.2* 0.5 1.4*
Cancer 0.9 1.0 0.9 1.4* 1.2 1.3* 0.3 1.4*
Stroke 0.8 1.6* 1.2 1.5* 0.2 1.3*
Depression 0.7 1.5* 0.8 5.9*
Heart failure 0.2 1.5*
1Prevalence estimates are standardized according to the age and sex distribution in the Dutch population in 2008.
2 The odds ratio represents the ‘probability’ for co-occurrence of 2 chronic diseases. Two chronic diseases co-occur more frequent than would be expected on
basis of independency if the odds ratio is larger than 1.0 and the 95% confidence interval does not include 1.0.
3 The prevalence of comorbidity of diabetes mellitus and coronary heart disease is 3.6%. Diabetes mellitus and coronary heart disease co-occur significantly more
frequent than expected on basis of independency, with an odds ratio of 1.9.
* Co-occurrence of diseases occurred more frequent than expected on basis of independency (p < 0.05).
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found for the disease pairs depression and anxiety dis-
order, coronary heart disease and heart failure, and
COPD and heart failure.
Over 70% of those with one of the selected 10 chronic
diseases had also one or more other chronic diseases
(comorbidity). The highest proportion of comorbidity is
shown for heart failure, of all patients with heart failure
92% had at least one extra chronic disease (Figure 1).
About a quarter of the patients with heart failure had one
extra disease, 23% two extra diseases, 21% three extra dis-
eases, and 22% had four or more extra chronic diseases.
Diabetes mellitus, osteoarthritis, and coronary heart
disease were the most prevalent co-occuring diseases for
all 10 diseases (Table 4). From all patients with cancer
and one or more extra diseases, 26% was recorded with
diabetes mellitus, 24% with coronary heart disease, 23%
with osteoarthritis, 19% with chronic neck- or back dis-
orders, and 18% with COPD. One-third of those with
cancer and comorbidity had only diseases included in
the top-5 comorbid diseases for cancer, the other
patients (two-thirds) had at least one disease that was
not included in the top-5 comorbid diseases for cancer.
Similar numbers were shown for the 9 other specific dis-
eases (Table 4): about 30% of the patients with comor-
bidity had only diseases included in the top-5 whereas
70% had one or more diseases not included in the top-5.
Discussion
Our analyses show that multimorbidity is common, espe-
cially among older persons, and that among those with achronic disease over two thirds has other comorbidities. A
more detailed look at the combinations of diseases showed
a wide variety in multimorbidity. We observed that all
chronic diseases tend to cluster, i.e. most disease pairs co-
occur more often than expected by chance. Furthermore,
the top-5 of co-occurring chronic diseases represents only
a minor proportion of the comorbidity: all diseases co-
occur together. These findings may have important conse-
quences since the organization and funding of health care
is organized by disease-specific programs in many coun-
tries. Such disease-specific approaches do not match the
reality of most people with a chronic disease.
Strengths and weaknesses of the study
Primary care registries represent an interesting source to
describe multimorbidity of chronic diseases because
often most health problems are known and recorded by
the general practitioner, especially in countries as the
Netherlands where general practice is the entry point for
health care and general practitioners act as gatekeeper
for secondary care. Analyzing multimorbidity among
general practice patients can be used for different re-
search questions [3,4,19,20] but ideally we need to know
the underlying population or epidemiological denomin-
ator. Strength of general practice registries in the Neth-
erlands is that almost everybody is registered within a
general practice. Hence, it is possible to use morbidity
data from the general practice registries to describe mor-
bidity of the general population.
In addition, use of long-term registration data of a
country-wide network of general practices for the
Figure 1 Prevalence of 10 chronic diseases and comorbidity (%) among patients of 55 years and older.
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the distribution of the general practices over the Neth-
erlands, the relatively long registration period, and the
standardized registration procedures. A general strength
of general practice medical records compared to self-
reported data is the availability of diagnosed chronic
diseases. A disadvantage is that diseases for which
patients do not consult a general practitioner are not in
the general practitioners’ medical record system. In
addition, the small group of elderly in nursing homes,
usually having more than one chronic disease, are gen-
erally not registered within a general practice. Owing to
these exclusions the prevalence of chronic diseases in
the general population may be underestimated based
on general practice registrations. Underdiagnosis andunderreporting of health problems like depression
may also lead to underestimation of the prevalence of
multimorbidity.
Length of follow-up in a registration affects the extent
and the reliability of multimorbidity estimates [21]. The
frequency of general practitioner consultations for some
diseases, such as osteoarthritis, are even less than once a
year. The prevalence of those diseases is underestimated
in a registration with a one-year follow-up, therefore the
minimum patient follow-up in our study was three years.
With a longer follow-up period selection may play a role
since patients move away and general practices drop out
from the registration.
Apparently, the prevalence of multimorbidity in this
study is completely determined by the selection of 29
Table 4 Top 5 of most prevalent comorbidity for 10 chronic diseases (first column) and prevalence of co-occuring diseases among all patients of 55 years and
older with the specific chronic disease and comorbidity
Chronic disease Comorbidity top 5 and prevalence Contribution of top
5 to all comorbidity
with the specific
chronic disease*
1 2 3 4 5
Diabetes mellitus Coronary heart
disease
30.0% Osteoarthritis 22.7% Chronic neck or
back disorder
20.3% Heart failure 18.1% COPD 17.2% 31.5%
Coronary heart
disease
Diabetes mellitus 33.5% Heart failure 25.5% Osteoarthritis 23.0% Chronic neck or
back disorder
20.8% Cancer 16.7% 32.8%
Osteoarthritis Chronic neck or
back disorder
26.8% Diabetes mellitus 26.0% Coronary heart
disease
23.6% Visual disorder 16.4% Cancer 16.0% 33.5%
COPD Asthma 32.4% Coronary heart
disease
27.4% Diabetes mellitus 25.8% Heart failure 24.0% Osteoarthritis 20.5% 29.9%
Chronic neck or
back disorder
Osteoarthritis 31.5% Diabetes mellitus 27.3% Coronary heart
disease
25.2% COPD 17.0% Cancer 15.5% 35.8%
Cancer Diabetes mellitus 25.6% Coronary heart
disease
24.4% Osteoarthritis 22.8% Chronic neck or
back disorder
18.8% COPD 18.3% 33.1%
Stroke Diabetes mellitus 32.4% Coronary heart
disease
26.0% Osteoarthritis 21.0% Heart failure 20.2% COPD 17.5% 27.8%
Depression Osteoarthritis 24.7% Diabetes mellitus 24.6% Coronary heart
disease
22.8% Chronic neck or
back disorder
22.3% COPD 18.0% 26.4%
Heart failure Coronary heart
disease
42.0% Diabetes mellitus 33.3% COPD 29.4% Osteoarthritis 24.5% Stroke 18.0% 30.4%
Anxiety disorder Depression 38.0% Diabetes mellitus 22.3% Chronic neck or
back disorder
22.2% Coronary heart
disease
20.7% Osteoarthritis 19.8% 31.4%
1 Prevalence is determined by dividing the number of patients with a specific combination of co-occuring diseases through the number of patients with the specific chronic disease and 1 or more other chronic
diseases. Prevalence estimates are standardized according to the sex and age distribution in the Dutch population in 2008.
* According to the selection of 29 chronic diseases in Table 1.
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conditions are included the higher prevalence rates of
multimorbidity will be found. We presume that an im-
portant part of chronic morbidity is included in our se-
lection of diseases. By counting the number of chronic
diseases we did not take into account any differences in
the severity of diseases [22]. When interpreting the
results of our and similar studies that are based on gen-
eral practice registrations, it should be noticed that the
varying consequences of diseases on patients’ physical
and mental functioning, disability and independency are
not considered [8,23].
Comparison with literature
Registry characteristics affect the prevalence and nature
of multimorbidity, especially the selection and definition
of diseases affect the actual prevalence rates [21,24].
This limits comparisons with other studies, even those
based on general practice registries. However, the gen-
eral patterns we found are similar to those of other
studies. First, multimorbidity being rather the rule than
the exception and prevalences increasing with age but
also found at younger age [3-8,25-27]. Second, cluster-
ing of diseases is commonly found in all recent studies
on multimorbidity of (chronic) diseases [5,28-32]. Third,
the most prevalent diseases like heart disease, diabetes
and osteoarthritis end up high in every multimorbidity
rank [4,29]. Most studies showed hypertension, obesity
and hyperlipidemia to rank high in prevalence when it
was defined as a chronic disease [21,28,29]. To our
opinion these are chronic conditions that increase the
risk on chronic disease but are not diseases, we there-
fore did not include these in our analyses. Fourth, a ma-
jority of persons with one chronic disease also have at
least one (and often more) other disease and these are
not limited to a few common diseases, these can be any
disease [6,28,29]. While a descriptive approach was used
in our analyses and others [6,29] few other studies per-
formed cluster analyses to identify comorbidity patterns
[28,30-32]. These studies identified 3 to 6 clusters of
diseases and most revealed a cluster with vascular con-
ditions and a cluster with mental diseases along with
pain [28,30,32]. We focused on common co-occuring
conditions and our findings indicate a wide variety of
co-occuring conditions since only 30% of the comorbid-
ity spectrum can be attributed to the 5 most common
comorbidities. In line with this, van den Bussche
described that combinations of the six most prevalent
chronic conditions span only 42% of the comorbidity
spectrum [29].
Implications of the study
A substantial proportion of the older population being
characterized by multimorbidity of chronic diseasesrequires reconsiderations of medical research as well as
the organization of care. Most research and clinical prac-
tice are based on a single disease paradigm, which may
not be appropriate for patients with multiple complex
health problems [33,34]. Studies investigating the (cost-)
effectiveness of new treatments commonly exclude
patients with multimorbidity. Findings from these stud-
ies have a very limited reach since multimorbidity affects
the majority of the aged. There is thus a clear need to
shift research from disease-specific treatments and
patients with single diseases to research which takes into
account multimorbidity or is explicitly focused on
patients with multimorbidity [35].
Multimorbidity leads to complex care through the use
of different treatment strategies and the involvement of
various health care professionals, which may lead to op-
posing advices (counseling) or medications [36]. Due to
fragmented expertise and focus by different care provi-
ders, patients preferences, expectancies, values and
needs regarding their daily life are often overlooked [37].
Patients’ main priorities are usually an adequate quality
of life and appropriate daily functioning in addition to
the improvement of disease-specific health problems.
Currently, disease management programs are imple-
mented worldwide in order to enhance quality and con-
tinuity of care for the chronically ill [38,39]. These
programs are characterized by a patient-centered ap-
proach of coordinated multiple healthcare interventions
that structure chronic care to a specific patient group
[39,40]. However, participating in multiple single-disease
oriented programs in combination with regular primary
care, may lead to fragmented care. In designing these
programs insufficient attention is paid to multimorbid
conditions. Multimorbid patients are therefore at risk
for suboptimal treatment, unsafe care, inefficient use of
health care services, unnecessary costs and consequently
run higher risks for adverse events [41]. Case manage-
ment is a potential model which might counteract frag-
mented care for multimorbid patients. It is an
individualized care program which coordinates all care
involved for patients enrolled in different single-disease
management programs, who have to adhere to various
treatment protocols. It draws on evidence-based optimal
care for systematically managing all existing conditions
in a patient, and is tailored to the individual patients’
preferences [42-44].
The finding that multimorbidity cannot be captured
with a few common combinations of diseases represents
a challenge for disease-specific treatment as well as
disease-specific disease management programs and rises
the question for which patient group case management
should be implemented. Given the enormous variety in
multimorbidity, we need more knowledge about the co-
occurring conditions that are leading to a high need for
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in functional limitations.
Conclusion
Multimorbidity is common at all ages and cannot be
captured by a few common combinations of diseases.
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